The basal subtype of breast carcinomas may represent the group of breast tumors that could benefit from EGFR-targeted therapies.

MLA

Siziopikou, Kalliopi P., and Melody Cobleigh. “The Basal Subtype of Breast Carcinomas May Represent the Group of Breast Tumors That Could Benefit from EGFR-Targeted Therapies.” Breast (Edinburgh, Scotland), vol. 16, no. 1, Feb. 2007, pp. 104–07. EBSCOhost, https://doi.org/10.1016/j.breast.2006.09.003.

APA

Siziopikou, K. P., & Cobleigh, M. (2007). The basal subtype of breast carcinomas may represent the group of breast tumors that could benefit from EGFR-targeted therapies. Breast (Edinburgh, Scotland), 16(1), 104–107. https://doi.org/10.1016/j.breast.2006.09.003

Chicago

Siziopikou, Kalliopi P, and Melody Cobleigh. 2007. “The Basal Subtype of Breast Carcinomas May Represent the Group of Breast Tumors That Could Benefit from EGFR-Targeted Therapies.” Breast (Edinburgh, Scotland) 16 (1): 104–7. doi:10.1016/j.breast.2006.09.003.